Get started
Author

J. Boonstra

Observed names: J. M. Boonstra, Jasper Boonstra, Jasper M Boonstra, Jasper Martijn Boonstra
ORCID: 0009-0006-5957-7244
Observed ORCID: 0009-0006-5957-7244
OpenAlex ID: A5083759143
Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis
2017 · J. M. Boonstra, K. C. van der Elst, et al. · Antimicrobial Agents and Chemotherapy · 47
PDF
Invasive Candidiasis in the Elderly: Considerations for Drug Therapy
2018 · B. G. J. Dekkers, A. Veringa, et al. · Drugs & Aging · 40
PDF
Simple and Robust LC–MS/MS Analysis Method for Therapeutic Drug Monitoring of Micafungin
2018 · Jasper M Boonstra, Erwin M Jongedijk, et al. · Bioanalysis · 11
Population Pharmacokinetic Model and Optimal Sampling Strategies for Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis
2022 · J. M. Boonstra, K. C. van der Elst, et al. · Antimicrobial Agents and Chemotherapy · 5
Development of an extemporaneous preparation formulation using a simple and non-solubilizing matrix for first in human clinical study
2024 · Cheng W. Chiang, Shijia Tang, et al. · International Journal of Pharmaceutics · 4
Reply to Van Daele et al., “Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?”
2021 · A.-G. Märtson, J. M. Boonstra, et al. · Antimicrobial Agents and Chemotherapy · 1
Exploring exposure guided treatment optimisation of antifungal drugs in critically-ill patients with invasive candidiasis
2023 · Jasper Boonstra · University of Groningen research database (University of Groningen / Centre for Information Technology)
Works count: 7
Citation count: 108
H-index: 4
I10-index: 3
Year
Topic
Type